Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

936
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
936
Nephrons01:10

Nephrons

8.1K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
8.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

570
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
570
Pedigree Analysis01:35

Pedigree Analysis

90.4K
Overview
90.4K
Renal Corpuscle01:20

Renal Corpuscle

8.2K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.2K
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

4.4K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing cardiovascular risk in Belgium through practical and measurable initiatives: a multidisciplinary expert-led call to action.

Acta cardiologica·2026
Same author

Infusion of human mesenchymal stromal cells during normothermic machine perfusion of porcine kidneys: a randomized, blinded, preclinical study.

Scientific reports·2026
Same author

[Environmental factors and tubulointerstitial nephropathy : the paradigm of «chronic interstitial nephritis in agricultural communities» (CINAC)].

Revue medicale de Liege·2026
Same author

From Preservation to Regeneration: Stem Cell-Derived Therapies in Machine-Perfused Kidney Transplants - A systematic Review and Meta-analysis.

Kidney & blood pressure research·2026
Same author

The First Case of Kleefstra Syndrome in a Rwandan Patient with Global Developmental Delay.

Genes·2026
Same author

[How I investigate primary aldosteronism].

Revue medicale de Liege·2026

Related Experiment Video

Updated: Mar 13, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

12.1K

[Autosomal dominant polycystic kidney disease].

Charlotte Leemans1, Laura Massoz2, Romain Gillard3

  • 1Service de Néphrologie, CHU Liège, Belgique.

Revue Medicale De Liege
|March 12, 2026
PubMed
Summary

Autosomal dominant polycystic kidney disease (ADPKD) management is updated with KDIGO recommendations. Tolvaptan shows promise for slowing kidney enlargement and preserving function in high-risk patients.

Keywords:
CystsImagingKidneyLiverPolycystic diseasegenetics

More Related Videos

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

10.3K
Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
08:13

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

Published on: February 20, 2015

14.0K

Related Experiment Videos

Last Updated: Mar 13, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

12.1K
Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

10.3K
Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
08:13

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

Published on: February 20, 2015

14.0K

Area of Science:

  • Nephrology
  • Genetics
  • Internal Medicine

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, driven by PKD1/PKD2 gene variants.
  • ADPKD causes progressive kidney enlargement (TKV) and declining kidney function (eGFR), with systemic effects including liver cysts and cardiovascular risks.
  • The Mayo Imaging Classification and PROPKD score aid in identifying rapid disease progression and guiding therapy eligibility.

Purpose of the Study:

  • To synthesize the latest KDIGO international recommendations for managing ADPKD.
  • To highlight current therapeutic strategies, including disease-modifying treatments like Tolvaptan.
  • To outline comprehensive care, including monitoring, lifestyle modifications, and management of extrarenal manifestations.

Main Methods:

  • Review and synthesis of recently published KDIGO international guidelines for ADPKD management.
  • Inclusion of data on disease progression markers like height-adjusted TKV, age, and eGFR slope.
  • Consideration of clinical trial outcomes for disease-modifying therapies such as Tolvaptan.

Main Results:

  • Tolvaptan effectively slows kidney enlargement and preserves eGFR in high-risk ADPKD patients.
  • Comprehensive management involves blood pressure control, hydration, sodium restriction, and cardiovascular risk reduction.
  • Targeted screening for hepatic and neurological complications is recommended for selected patients.

Conclusions:

  • Updated KDIGO guidelines provide a framework for optimizing ADPKD care.
  • Tolvaptan offers a disease-modifying option requiring careful monitoring for efficacy and side effects.
  • Future research focuses on precision medicine, biomarkers, and novel therapies to improve ADPKD outcomes.